Xinxiang Hengfeng Bamboo Products Co., Ltd. – Trademark Portfolio

Entity Type: 99

Xinxiang Hengfeng Bamboo Products Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include BABYOOK. The owner is based in Xinxiang, Henan.

No. 76, Zhongxing Rd., Zhongzhangju Vil.

Sizhuang Town, Huojia County

Xinxiang, Henan 453000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BABYOOK
BABYOOK
Registered 2022

Trademark Classifications

Xinxiang Hengfeng Bamboo Products Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Xinxiang Hengfeng Bamboo Products Co., Ltd. have?

Xinxiang Hengfeng Bamboo Products Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Xinxiang Hengfeng Bamboo Products Co., Ltd. file in?

Xinxiang Hengfeng Bamboo Products Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Xinxiang Hengfeng Bamboo Products Co., Ltd.'s most well-known trademarks?

Xinxiang Hengfeng Bamboo Products Co., Ltd.'s registered trademark portfolio includes well-known marks such as BABYOOK. These are among 1 currently registered trademark in the portfolio.

What is Xinxiang Hengfeng Bamboo Products Co., Ltd.'s trademark registration success rate?

Xinxiang Hengfeng Bamboo Products Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.